Donegal Group 3Q 2026: Revenue $237.66M — 10-Q Summary

Donegal Group reported 3Q 2026 revenue of $237.66M, down 3.4% YoY, and net income of $18.16M, down 9.6% YoY. Premiums earned and written declined due to lower retention and renewal premiums, partially offset by new business growth. Investment income rose, but investment results shifted to a loss. The combined ratio increased to 96.5%.

Original reporting
Published Nov 5, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Donegal Group 3Q 2026: Revenue $237.66M — 10-Q Summary — source image
Decision brief

The 30-second read

$DGICABearishMed
01

Why it matters

The earnings miss could trigger short‑term sell‑offs, but the improved investment income and sub‑100% combined ratio may offer upside if the market overreacts.

02

Market read

Micro‑cap insurance stock with fresh earnings data; potential short‑term price move.

03

What to watch

Investment income rose 5.4% and the combined ratio remains below 100%, indicating operational resilience.

Relevance 6/10Novelty 8/10Timing: post‑market release

Background

Donegal Group Inc. filed its Q3 2026 10‑Q, showing modest revenue decline and a sharper drop in net income.

Company-level read

Ticker impact

$DGICABearishHigh confidence
Context

Q3 2026 revenue fell 3.4% YoY to $237.66M and net income dropped 9.6% to $18.16M, marking the first public filing of these results.

Expected impact

likely downward pressure as investors price in lower top‑line and earnings.

Evidence & confidence

The 10‑Q provides fresh, material financial metrics for a micro‑cap insurer; declines are unexpected and can move the stock.

Market effects

May signal pressure on the regional insurance sector if similar trends appear.

Limited to U.S. micro‑cap insurance niche.

Low; impact confined to niche investors.

Counterpoint

If the decline is viewed as temporary and the company can improve retention, the stock may be undervalued.

Key entities

  • Donegal Group Inc.

    U.S. insurer reporting Q3 2026 results.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o